Inovalon Investor Conference Presentation Deck
Benefits of Inovalon's Massive Primary-Source Dataset
The significant size, extensive breadth of data types, historical duration, recency timeliness, and fully linkable primary-sourced nature of Inovalon's
datasets provides a uniquely rich, longitudinally matched real-world dataset able to empower highly differentiated and highly valued capabilities.
Training Advanced Artificial Intelligence Algorithms
Key to the development, training, and improvement of
AI, ML, and DL algorithms is the depth, breadth,
timeline duration, and timeliness of training datasets.
As a result of Inovalon's unique datasets, the
Company is able to apply a wide array of advanced
machine learning, artificial intelligence, and deep
learning algorithms to achieve highly differentiated,
high-value impact within the Company's applications.
Enabling Outcomes-Based and Relative-Performance Analytics
All value-based engagements, outcomes-based contracts, risk-based payment
models, and all quality incentive programs are based on relative performance -
graded on a dynamic curve. Without knowing how the relevant comparative
population is performing today, healthcare organizations are shooting in the dark,
potentially wasting critical resources on the wrong issues.
#Healthcare
Organization
INOV Investor Presentation (1.14.20) v1.0.0
Informing Patient-Specific & Consumer Solutions
Healthcare is moving in a direction of increasing patient-specific
engagements and consumerism focused offerings. The breadth,
depth, and primary source nature of Inovalon's datasets is highly
valuable and uniquely able to empower and deliver highly
granular patient-specific consumer-focused insights, details, and
empowerment, bringing to life what is believed to be the largest
transformation segment of healthcare in the years ahead.
Further, patient-specific data eliminates time-delays and
operational costs otherwise caused today within the market when
additional or confirmatory information is needed with respect to a
specific patient or case.
Supporting Large-Scale Real World Evidence (RWE)
Research and Insights
Inovalon's very-large scale RWE datasets empowers the
Company to deliver solutions of great value to the
pharmaceutical, device manufacturer, and research
marketplace. RWE enables the healthcare ecosystem to make
highly informed models, algorithms and decisions for numerous
use cases including diagnosis and treatment protocol
determination tools, clinical trial design and execution,
medication formulary optimization, outcomes-based contract
structuring and honing, payment model design, and many other
use cases.
?
D
11010110
01101011
GDD
9View entire presentation